Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Reinhold Website

William C. Reinhold, B.S.

Portait Photo of William Reinhold
Developmental Therapeutics Branch
Facility Head
Center for Cancer Research
National Cancer Institute
Building 37, Room 5401
Bethesda, MD 20892-4255
Phone:  
301-496-9571
Fax:  
301-402-0752
E-Mail:  
wcr@mail.nih.gov

Biography

William Reinhold is currently operating as facility head of the Genomics and Bioinformatics Group in the Laboratory of Molecular Pharmacology. He has been a part of this section since April 1998, working with first John N. Weinstein, and then Yves Pommier. He has been central in generating multiple datasets for the NCI-60 cancerous cell lines, available at the CellMiner web-application at http://discover.nci.nih.gov/cellminer/. His activities include running the web site, and maintaining the contracts required to do so, as a Contracting Officer Representative (COR). He helps in the dissemination and interpretation of this data, encouraging and facilitation collaborations.

Prior to this period of time he has also held positions with the Laboratory of Molecular Pharmacology (Sept. 1996 to April 1998), Laboratory of Biological Chemistry and Medicine Branch in the NCI (February 1992 - September 1996), at the National Institutes of Neurological Diseases and Stroke (Sept.-1989 to Feb.-1992), National Institutes of Allergies and Infectious Diseases June 1982 to Aug. 1989), as well as in private industry, working for Gibco BRL (April 1981 to Feb. 1982), and Meloy Laboratories (Jan. 1978 to April 1981).

He received his B.S. in Biochemistry from the University of Maryland in 1978, and has 66 pier reviewed publications to date.

Research

Currently our research includes the collection of data for the NCI-60 cancerous cell lines, and the development of software to facilitate the use of this data in systems pharmacology. We currently provide easy integration for 20, 602 compounds (including 102 FDA-approved drugs, and 53 in clinical trial), 26,065 genes, and 350 microRNAs. The user selects their input parameter of interest (example: a gene, drug, microRNA, or any other criteria of interest).

This page was last updated on 7/14/2014.